Asvall J, Haugaa H, Larsen S G, Skarholt T F R, Botnen B M, Flatmark K, Tønnessen T I, Thorgersen E B
Department of Research and Development, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tech Coloproctol. 2025 May 29;29(1):126. doi: 10.1007/s10151-025-03156-w.
Patients with locally advanced rectal cancer (LARC) treated with (chemo)-radiotherapy before abdominoperineal resection (APR) are at high risk of developing pelvic organ/space surgical site infection (O/S-SSI). This increases morbidity and prolongs length of stay. Vague symptoms delay diagnosis. In microdialysis, thin catheters are placed in tissue enabling monitoring of metabolism. We hypothesize that local metabolic changes related to O/S-SSI might be detected by microdialysis.
In a prospective observational study, 38 patients who underwent open APR for LARC were analysed. At the end of surgery microdialysis catheters were placed in remnant tissue of the pelvic floor. Postoperatively, metabolic parameters including lactate, pyruvate, glucose and glycerol were measured, and the lactate-to-pyruvate (L/P) ratio was calculated. Out of 38 patients, 12 (32%) developed O/S-SSI.
O/S-SSI was diagnosed median 9 (range 6-17) days after surgery. On the day of surgery, mean lactate in the O/S-SSI group was 6.0 mmol/L, whereas it was 3.6 mmol/L in the no-O/S-SSI group. ROC analysis (AUC = 0.73), with cut-point lactate 5.7, detected O/S-SSI with 92% sensitivity and 65% specificity. Overall mean lactate was 1.9 mmol/L higher in the O/S-SSI group than in the no-O/S-SSI group (P = 0.002). Overall mean L/P ratio was 34 units higher in the O/S-SSI group (P = 0.001).
In patients developing pelvic O/S-SSI, tissue lactate and L/P ratio measured by microdialysis were significantly higher and evident already from the day of surgery, 9 days prior to diagnosis, with high negative predictive value and moderate positive predictive value. Local monitoring using microdialysis may aid detection of O/S-SSI.
接受腹会阴联合切除术(APR)前接受(化疗)放疗的局部晚期直肠癌(LARC)患者发生盆腔器官/腔隙手术部位感染(O/S-SSI)的风险很高。这会增加发病率并延长住院时间。症状不明确会延迟诊断。在微透析中,细导管放置在组织中以监测代谢情况。我们假设微透析可能检测到与O/S-SSI相关的局部代谢变化。
在一项前瞻性观察研究中,对38例行开放性APR治疗LARC的患者进行分析。手术结束时,将微透析导管放置在盆底残留组织中。术后,测量包括乳酸、丙酮酸、葡萄糖和甘油在内的代谢参数,并计算乳酸与丙酮酸(L/P)比值。38例患者中,12例(32%)发生了O/S-SSI。
O/S-SSI在术后中位9天(范围6-17天)被诊断出来。手术当天,O/S-SSI组的平均乳酸水平为6.0 mmol/L,而无O/S-SSI组为3.6 mmol/L。ROC分析(AUC = 0.73),切点乳酸为5.7时,检测O/S-SSI的灵敏度为92%,特异度为65%。O/S-SSI组的总体平均乳酸水平比无O/S-SSI组高1.9 mmol/L(P = 0.002)。O/S-SSI组的总体平均L/P比值高34个单位(P = 0.001)。
在发生盆腔O/S-SSI的患者中,通过微透析测量的组织乳酸和L/P比值显著更高,且在诊断前9天的手术当天就已明显,具有高阴性预测值和中等阳性预测值。使用微透析进行局部监测可能有助于检测O/S-SSI。